Top 10 late-stage cancer drugs in 2012

Top 10 late-stage cancer drugs in 2012

Submitted by admin on April 18, 2012 - 12:11pm
Source: 
Fierce Biotech
News Tags: 
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Headline: 
Top 10 late-stage cancer drugs in 2012

Do Not Allow Advertisers to Use My Personal information